Somatic hypermutation (SHM) drives the genetic diversity of Ig genes in activated B cells and supports the generation of Abs with increased affinity for Ag. SHM is targeted to Ig genes by their enhancers (diversification activators [DIVACs]), but how the enhancers mediate this activity is unknown. We show using chicken DT40 B cells that highly active DIVACs increase the phosphorylation of RNA polymerase II (Pol II) and Pol II occupancy in the mutating gene with little or no accompanying increase in elongation-competent Pol II or production of full-length transcripts, indicating accumulation of stalled Pol II. DIVAC has similar effect also in human Ramos Burkitt lymphoma cells. The DIVAC-induced stalling is weakly associated with an increase in the detection of ssDNA bubbles in the mutating target gene. We did not find evidence for antisense transcription, or that DIVAC functions by altering levels of H3K27ac or the histone variant H3.3 in the mutating gene. These findings argue for a connection between Pol II stalling and cis-acting targeting elements in the context of SHM and thus define a mechanistic basis for locus-specific targeting of SHM in the genome. Our results suggest that DIVAC elements render the target gene a suitable platform for AID-mediated mutation without a requirement for increasing transcriptional output.
- MeSH
- Lymphocyte Activation MeSH
- Burkitt Lymphoma genetics immunology MeSH
- Cytidine Deaminase genetics MeSH
- Transcription, Genetic MeSH
- Immunoglobulins genetics metabolism MeSH
- Chickens MeSH
- Humans MeSH
- Mutation genetics MeSH
- Mutagenesis, Site-Directed MeSH
- B-Lymphocyte Subsets immunology MeSH
- Avian Proteins genetics metabolism MeSH
- RNA Polymerase II genetics metabolism MeSH
- Antibody Diversity MeSH
- Somatic Hypermutation, Immunoglobulin MeSH
- Enhancer Elements, Genetic genetics MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
